Supreme Court: Docs cannot sue over low Medicaid payments
Physicians cannot sue state governments over low Medicaid payments, the U.S. Supreme Court ruled. In a 5-4 decision,... More
FDA strengthens allergy warning for IV anemia therapy ferumoxytol
The warning about potentially life-threatening allergic reactions with the intravenous anemia drug ferumoxytol is being... More
Supreme Court won’t hear IPAB challenge
The Supreme Court has declined to hear a case challenging the Independent Payment Advisory... More
Jessica Chubak, Ph.D.
BIRMINGHAM, ALA.– The time to colonoscopy after a positive fecal occult blood test varied widely between health systems... More
Commonwealth Fund: ACA’s medical loss ratio rule saves $5 billion
The Affordable Care Act’s requirement that health insurers pay out a minimum percentage of premiums in medical claims... More
Senate recesses without addressing SGR repeal bill
The Senate adjourned for a 2-week recess early on March 27, leaving without taking action on House-passed legislation... More
Rep. Michael C. Burgess
Physicians are lauding passage of legislation by the House of Representatives to repeal the Medicare Sustainable Growth... More
Dr. Susan Rose
SAN DIEGO – Remain vigilant for endocrine side effects after reduced-intensity conditioning for hematopoietic stem cell... More
CMS: All docs, hospitals must be on Stage 3 meaningful use in 2018
All physicians and hospitals would need to be meet stage 3 meaningful use beginning in 2018, according to a recent... More
Medicare advisers: Cancer prognostic tests not ready for prime time
BALTIMORE – While prognostic tests tied to specific chemotherapy agents may offer a clear benefit in guiding treatment... More
VIDEO: Sun protection urged for Asian, Hispanic women
SAN FRANCISCO – Among Asian and Hispanic patients, women are more likely than men are to get nonmelanoma skin cancer,... More
HHS Secretary Sylvia M. Burwell
The federal government has launched the Health Care Payment Learning and Action Network as a way to help physicians and... More

News

GREGORY TWACHTMAN
Physicians cannot sue state governments over low Medicaid payments, the U.S. Supreme Court ruled. In a 5-4 decision, the high court overturned a decision by the 9th Circuit Court of Appeals that said physicians and other providers could sue to hold ... More »
 

News

A group of experts has been assembled to plan a course for President Obama’s recently announced Precision Medicine Initiative, according to a written statement issued by the National Institutes of Health. The initiative, launched in late January, ... More »
 

Practice Economics

Reimbursement and Management

GREGORY TWACHTMAN
Physicians cannot sue state governments over low Medicaid payments, the U.S. Supreme Court ruled. In a 5-4 decision, the high court overturned a decision by the 9th Circuit Court of Appeals that said physicians and other providers could sue to hold ... More »
 
GREGORY TWACHTMAN
The Supreme Court has declined to hear a case challenging the Independent Payment Advisory Board. ©trekandshoot/thinkstockphotos.com This leaves in place a ruling from the 9th U.S. Circuit Court of appeals, which dismissed the lawsuit Coons v. Le... More »
 

Commentaries

Yes: Both patients and science can benefit from genomic analysis of tumors. Use of molecular profiling of gastrointestinal tumors is ready for prime time. My contention is that both patients and science can benefit from genomic analysis of tumors. ... More »
 

Commentaries

JEFFREY BENABIO, M.D.
Doctors have been conjecturing about how the new Apple Watch, with its spectacular fitness and wellness tracking features, will transform health care. The real rock star at Apple’s March 9 “Spring Forward” event, however, was the opening band, ... More »
 
RENEE MATTHEWS
SAN ANTONIO – In a roundtable at the 2014 San Antonio Breast Cancer Symposium, Dr. Jame Abraham, Dr. Linda Bosserman, and Dr. Debra Patt discussed their top selections from the meeting’s presentations. Among the topics were the promising findin... More »
 
Yes: Both patients and science can benefit from genomic analysis of tumors. Use of molecular profiling of gastrointestinal tumors is ready for prime time. My contention is that both patients and science can benefit from genomic analysis of tumors. ... More »